These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 12971653)

  • 1. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
    Salaniponi FM; Gausi F; Mphasa N; Nyirenda TE; Kwanjana JH; Harries AD
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision.
    Banerjee A; Harries AD; Mphasa N; Nyirenda TE; Veen J; Ringdal T; Van Gorkom J; Salaniponi FM
    Int J Tuberc Lung Dis; 2000 Apr; 4(4):333-9. PubMed ID: 10777082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.
    Floyd K; Skeva J; Nyirenda T; Gausi F; Salaniponi F
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S29-37. PubMed ID: 12971652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi.
    Nyirenda TE; Harries AD; Gausi F; van Gorkom J; Maher D; Floyd K; Salaniponi FM
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S21-8. PubMed ID: 12971651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditing the new decentralised oral treatment regimens in Malawi.
    Nyirenda TE; Harries AD; Gausi FK; Ito K; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1089-94. PubMed ID: 15455593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decentralisation of tuberculosis treatment from the main hospitals to the peripheral health units and in the community within Machakos district, Kenya.
    Kangangi JK; Kibuga D; Muli J; Maher D; Billo N; N'gang'a L; Ngugi E; Kimani V
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S5-13. PubMed ID: 12971649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an unsupervised ambulatory treatment regimen for smear-negative pulmonary tuberculosis and tuberculous pleural effusion in Malawi.
    Harries AD; Nyangulu DS; Banda H; Kang'ombe C; Van der Paal L; Glynn JR; Subramanyam VR; Wirima JJ; Salaniponi FM; Maher D; Nunn P
    Int J Tuberc Lung Dis; 1999 May; 3(5):402-8. PubMed ID: 10331729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. True status of smear-positive pulmonary tuberculosis defaulters in Malawi.
    Kruyt ML; Kruyt ND; Boeree MJ; Harries AD; Salaniponi FM; van Noord PA
    Bull World Health Organ; 1999; 77(5):386-91. PubMed ID: 10361755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High early death rate in tuberculosis patients in Malawi.
    Harries AD; Hargreaves NJ; Gausi F; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Nov; 5(11):1000-5. PubMed ID: 11716335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes.
    Harries AD; Hargreaves NJ; Graham SM; Mwansambo C; Kazembe P; Broadhead RL; Maher D; Salaniponi FM
    Int J Tuberc Lung Dis; 2002 May; 6(5):424-31. PubMed ID: 12019918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis control in Bangladesh: success of the DOTS strategy.
    Kumaresan JA; Ahsan Ali AK; Parkkali LM
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):992-8. PubMed ID: 9869115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
    Harries AD; Gausi F; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When are follow-up sputum smears actually examined in patients treated for new smear-positive pulmonary tuberculosis?
    Harries AD; Gausi F; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):440-4. PubMed ID: 15141736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
    Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region.
    van den Boogaard J; Lyimo R; Irongo CF; Boeree MJ; Schaalma H; Aarnoutse RE; Kibiki GS
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1524-9. PubMed ID: 19919771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi.
    Harries AD; Nyirenda TE; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1040-4. PubMed ID: 14598962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi].
    Masuyama H; Takase A; Aoki M; Shimao T
    Kekkaku; 1998 Dec; 73(12):697-703. PubMed ID: 10028803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.
    Manders AJ; Banerjee A; van den Borne HW; Harries AD; Kok GJ; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):838-42. PubMed ID: 11573895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
    Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.